1. Home
  2. IGC vs MKTW Comparison

IGC vs MKTW Comparison

Compare IGC & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • MKTW
  • Stock Information
  • Founded
  • IGC 2005
  • MKTW 1999
  • Country
  • IGC United States
  • MKTW United States
  • Employees
  • IGC N/A
  • MKTW N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • MKTW Computer Software: Prepackaged Software
  • Sector
  • IGC Health Care
  • MKTW Technology
  • Exchange
  • IGC Nasdaq
  • MKTW Nasdaq
  • Market Cap
  • IGC 39.8M
  • MKTW 48.2M
  • IPO Year
  • IGC N/A
  • MKTW N/A
  • Fundamental
  • Price
  • IGC $0.41
  • MKTW $17.06
  • Analyst Decision
  • IGC Strong Buy
  • MKTW Hold
  • Analyst Count
  • IGC 2
  • MKTW 1
  • Target Price
  • IGC $4.00
  • MKTW $20.00
  • AVG Volume (30 Days)
  • IGC 1.3M
  • MKTW 10.9K
  • Earning Date
  • IGC 11-11-2025
  • MKTW 11-06-2025
  • Dividend Yield
  • IGC N/A
  • MKTW 4.64%
  • EPS Growth
  • IGC N/A
  • MKTW 59.71
  • EPS
  • IGC N/A
  • MKTW 2.83
  • Revenue
  • IGC $1,327,000.00
  • MKTW $358,121,000.00
  • Revenue This Year
  • IGC $15.26
  • MKTW N/A
  • Revenue Next Year
  • IGC $3.41
  • MKTW N/A
  • P/E Ratio
  • IGC N/A
  • MKTW $6.09
  • Revenue Growth
  • IGC 24.95
  • MKTW N/A
  • 52 Week Low
  • IGC $0.25
  • MKTW $9.08
  • 52 Week High
  • IGC $0.50
  • MKTW $21.74
  • Technical
  • Relative Strength Index (RSI)
  • IGC 51.81
  • MKTW 39.53
  • Support Level
  • IGC $0.38
  • MKTW $17.70
  • Resistance Level
  • IGC $0.44
  • MKTW $18.30
  • Average True Range (ATR)
  • IGC 0.03
  • MKTW 0.45
  • MACD
  • IGC -0.00
  • MKTW -0.04
  • Stochastic Oscillator
  • IGC 32.33
  • MKTW 7.14

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About MKTW MarketWise Inc.

Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.

Share on Social Networks: